Søren Tulstrup

Søren Tulstrup

Corporate Officer/Principal chez
Shire Human Genetic Therapies, Inc.
61 ans
Health Technology
Consumer Services

Profil

Søren Tulstrup currently works at Shire Human Genetic Therapies, Inc., as Senior Vice President from 2012.
Mr. Tulstrup also formerly worked at Vifor Pharma AG, as Chief Executive Officer from 2014 to 2016, Roche Innovation Center Copenhagen A, as President & Chief Executive Officer from 2008 to 2012, Vifor Pharma Management AG, as Chief Executive Officer, Hansa Biopharma AB, as President & Chief Executive Officer from 2018 to 2025, Organon Pharma (UK) Ltd., as Managing Director-Denmark, Abbott Laboratories, as Principal, Merck & Co., Inc., as Vice President-Global Human Health, Sandoz, Inc., as Principal, Novartis AG, as Deputy Regional Manager, and Shire Pharmaceuticals, Inc., as Senior Vice President from 2012 to 2014.
Mr. Tulstrup received his graduate degree from Northwestern University and undergraduate degree and graduate degree from Copenhagen Business School.

Dernières actualités sur Søren Tulstrup

Postes actifs de Søren Tulstrup

SociétésPosteDébut
Corporate Officer/Principal 26/09/2012

Anciens postes connus de Søren Tulstrup

SociétésPosteFin
HANSA BIOPHARMA AB Directeur Général 24/04/2025
Directeur Général 24/05/2016
VIFOR PHARMA Directeur Général 01/01/2016
Corporate Officer/Principal 01/01/2014
Directeur Général 01/01/2012
Voir l'expérience en détail de Søren Tulstrup

Formation de Søren Tulstrup

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Søren Tulstrup
🔇